Current Nutrition Management of Infants With Chronic Lung Disease

Abstract

Preterm infants with lung disease present nutrition challenges to health care providers. Malnutrition is common, develops shortly after birth, and may continue into early childhood. Although there are many studies identifying the nutrient deficiencies in infants with chronic lung disease, few randomized trials have explored the effects of nutrition support on the prevention and treatment of chronic lung disease. The purpose of this article is to review current practices and ongoing controversies in the nutrition management of infants with chronic lung disease.

Get full access to this article

View all access options for this article.

References

Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med. 1967 ;276:357– 368.

Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 2003;8:63– 71.

Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol. 2003 ;8:73– 81.

Berger TM, Bachmann II, Adams M, Schubiger G. Impact of improved survival of very low-birth-weight infants on incidence and severity of bronchopulmonary dysplasia. Biol Neonate. 2004 ; 86:124– 30.

Atkinson SA. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr. 2001 ; 131(Suppl):942S– 946S.

Brunton JA, Saigal S, Atkinson SA. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: a randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J Pediatr. 1998;133 :340– 345.

deRegnier RA, Guilbert TW, Mills MM, Georgieff MK. Growth failure and altered body composition are established by one month of age in infants with bronchopulmonary dysplasia. J Nutr. 1996 ;126:168– 175.

Huysman WA, de Ridder M, de Bruin NC, et al. Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed. 2003 ;88:F46– F51.

de Meer K, Westerterp KR, Houwen RH, Brouwers HA, Berger R, Okken A. Total energy expenditure in infants with bronchopulmonary dysplasia is associated with respiratory status. Eur J Pediatr. 1997 ;156:299– 304.

10.

Bauer J, Maier K, Muehlbauer B, Poeschl J, Linderkamp O. Energy expenditure and plasma catecholamines in preterm infants with mild chronic lung disease. Early Hum Dev. 2003 ;72:147– 157.

11.

Bauer J, Maier K, Linderkamp O, Hentschel R. Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics. 2001 ;107:660– 663.

12.

Carnielli VP, Verlato G, Benini F, et al. Metabolic and respiratory effects of theophylline in the preterm infant. Arch Dis Child Fetal Neonatal Ed. 2000;83:F39– F43.

13.

Fjeld CR, Cole FS, Bier DM. Energy expenditure, lipolysis, and glucose production in preterm infants treated with theophylline. Pediatr Res. 1992 ;32:693– 698.

14.

Leitch CA, Ahlrichs J, Karn C, Denne SC. Energy expenditure and energy intake during dexamethasone therapy for chronic lung disease. Pediatr Res. 1999 ;46:109– 113.

15.

Denne SC. Energy expenditure in infants with pulmonary insufficiency: is there evidence for increased energy needs? J Nutr. 2001;131(Suppl):935S– 937S.

16.

Chessex P, Belanger S, Piedboeuf B, Pineault M. Influence of energy substrates on respiratory gas exchange during conventional mechanical ventilation of preterm infants. J Pediatr. 1995 ; 126:619– 624.

17.

Pereira GR, Baumgart S, Bennett MJ, et al. Use of high-fat formula for premature infants with bronchopulmonary dysplasia: metabolic, pulmonary, and nutritional studies. J Pediatr. 1994;124 :605– 611.

18.

Wahlig TM, Gatto CW, Boros SJ, Mammel MC, Mills MM, Georgieff MK. Metabolic response of preterm infants to variable degrees of respiratory illness. J Pediatr. 1994 ;124:283– 288.

19.

Van Goudoever JB, Wattimena JD, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJ. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia. J Pediatr. 1994 ;124:112– 118.

20.

Haycock GB. The influence of sodium on growth in infancy. Pediatr Nephrol. 1993 ;7:871– 875.

21.

Perlman JM, Moore V, Siegel MJ, Dawson J. Is chloride depletion an important contributing cause of death in infants with bronchopulmonary dysplasia? Pediatrics. 1986 ;77:212– 216.

22.

Darlow BA, Graham PJ. Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants. Cochrane Database Syst Rev. 2002;(4):CD000501 .

23.

Darlow BA, Austin NC. Selenium supplementation to prevent short-term morbidity in preterm neonates. Cochrane Database Syst Rev. 2003;(4):CD003312 .

24.

Weiler HA, Paes B, Shah JK, Atkinson SA. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum Dev. 1997;47:271– 286.

25.

Howlett A, Ohlsson A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2003 ;(4): CD000366.

26.

Whitfield J, Smith T, Sollohub H, Sweetman L, Roe CR. Clinical effects of L-carnitine supplementation on apnea and growth in very low birth weight infants. Pediatrics. 2003 ;111:477– 482.

27.

Falciglia HS, Johnson JR, Sullivan J, et al. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Am J Perinatol. 2003;20:97– 107.

28.

Welty SE. Is there a role for antioxidant therapy in bronchopulmonary dysplasia? J Nutr. 2001 ;131(Suppl):947S– 950S.

29.

Thureen PJ, Melara D, Fennessey PV, Hay WW Jr. Effect of low versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res. 2003 ;53:24– 32.

30.

Rivera A Jr, Bell EF, Bier DM. Effect of intravenous amino acids on protein metabolism of preterm infants during the first three days of life. Pediatr Res. 1993 ;33:106– 111.

31.

Murdock N, Crighton A, Nelson LM, Forsyth JS. Low birthweight infants and total parenteral nutrition (TPN) immediately after birth, II: randomised study of biochemical tolerance of intravenous glucose, amino acids, and lipid. Arch Dis Child Fetal Neonatal Ed. 1995 ;73:F8– F12.

32.

Gilbertson N, Kovar IZ, Cox DJ, Crowe L, Palmer NT. Introduction of intravenous lipid administration on the first day of life in the very low birth weight neonate. J Pediatr. 1991 ;119:615– 623.

33.

Sosenko IR, Rodriguez-Pierce M, Bancalari E. Effect of early initiation of intravenous lipid administration on the incidence and severity of chronic lung disease in premature infants. J Pediatr. 1993;123:975– 982.

34.

Ziegler EE, Thureen PJ, Carlson SJ. Aggressive nutrition of the very low birthweight infant. Clin Perinatol. 2002 ;29:225– 244.

35.

Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics. 1999 ;103:1150– 1157.

36.

Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very low-birth-weight infants. Arch Pediatr Adolesc Med. 2003 ;157:66– 71.

37.

Akinola E, Rosenkrantz TS, Pappagallo M, McKay K, Hussain N. Gastroesophageal reflux in infants < 32 weeks gestational age at birth: lack of relationship to chronic lung disease. Am J Perinatol. 2004;21:57– 62.

38.

Romera G, Figueras J, Rodriguez-Miguelez JM, Ortega J, Jimenez R. Energy intake, metabolic balance and growth in preterm infants fed formulas with different nonprotein energy supplements. J Pediatr Gastroenterol Nutr. 2004;38:407– 413.

39.

Puangco MA, Schanler RJ. Clinical experience in enteral nutrition support for premature infants with bronchopulmonary dysplasia. J Perinatol. 2000;20:87– 91.

40.

Johnson DB, Cheney C, Monsen ER. Nutrition and feeding in infants with bronchopulmonary dysplasia after initial hospital discharge: risk factors for growth failure. J Am Diet Assoc. 1998 ;98:649– 656.

41.

Carver JD, Wu PY, Hall RT, et al. Growth of preterm infants fed nutrient-enriched or term formula after hospital discharge. Pediatrics. 2001 ;107:683– 689.